Global Endovascular Therapy Devices Market to Reach USD 9.3 Billion by 2035 Driven by Innovation and Rising Demand

The global Endovascular Therapy Devices Market is poised for strong expansion, growing from an estimated USD 4.8 billion in 2025 to USD 9.3 billion by 2035, at a compound annual growth rate (CAGR) of 6.8%. This growth reflects the rising prevalence of cardiovascular and vascular diseases, an aging population, and increasing adoption of minimally invasive therapies across hospitals and clinics worldwide.

Endovascular therapy, a minimally invasive procedure that uses catheters, stents, and grafts to treat vascular conditions, is rapidly gaining preference over traditional open surgery. Reduced patient risk, shorter recovery times, and improved clinical outcomes have positioned these devices at the forefront of modern cardiovascular treatment. With both global leaders and emerging manufacturers pushing boundaries in device design and patient care, the market is entering a transformative era.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-7693

Why the Market is Growing

The primary driver of this growth is the increasing incidence of cardiovascular diseases and peripheral arterial disorders. As populations age and lifestyles evolve, healthcare systems are seeing more patients requiring advanced vascular treatment. Endovascular interventions are becoming the gold standard for many conditions due to their minimally invasive approach.

Technology is another major catalyst. Advanced imaging tools, precision-guided delivery systems, and next-generation stents and grafts are enabling physicians to achieve higher success rates with lower risks. Moreover, reimbursement programs and growing hospital preferences for cost-effective treatment methods are further boosting adoption.

Emerging economies are also stepping into the spotlight. As healthcare infrastructure strengthens in Asia-Pacific, Latin America, and the Middle East, patients are gaining access to cutting-edge therapies that were once limited to developed regions. This democratization of healthcare access is expected to accelerate market momentum in the coming decade.

Key Market Segments

The market is segmented by product type, procedure, application, end user, and geography. Among these, percutaneous endovascular aneurysm repair (EVAR) is expected to lead in 2025, accounting for 36.4% of market revenue. The minimally invasive nature of EVAR procedures, supported by improvements in stent graft design and imaging systems, makes them highly attractive to physicians and patients alike.

On the procedural front, angioplasty with stent placement is projected to dominate with 41.2% of revenue in 2025. This is largely due to the rising prevalence of coronary artery and peripheral arterial diseases and the clinical efficiency of angioplasty procedures combined with stent placement.

From an application standpoint, cardiology emerges as the leading segment, estimated to represent 47.8% of revenue in 2025. The high global burden of cardiovascular diseases continues to demand innovative and minimally invasive solutions, ensuring cardiology remains the most significant driver of endovascular device adoption.

Regional Outlook

North America is expected to remain the largest regional market, supported by its advanced healthcare infrastructure, high disease prevalence, and strong presence of global leaders such as Medtronic, Boston Scientific, and Cardinal Health. Europe follows closely, with countries like Germany, France, and the UK driving growth through robust clinical adoption and technological advancements.

Asia-Pacific, particularly China and India, is forecasted to record the fastest growth rates, with CAGRs of 9.2% and 8.5% respectively. Expanding healthcare infrastructure, growing patient awareness, and the emergence of local manufacturers are creating immense opportunities in these regions. Latin America, led by Brazil, and the Middle East & Africa are also witnessing steady growth, fueled by liberalized healthcare policies and rising investments in medical technology.

Competitive Landscape

The market is highly competitive, with a strong mix of established global leaders and emerging innovators. Medtronic, Boston Scientific, Cardinal Health, Getinge, and Terumo continue to dominate through extensive product portfolios, research investments, and global distribution networks.

At the same time, newer players like Endospan, InspireMD, and Lifetech Scientific are carving their niche by introducing highly specialized and technologically advanced devices tailored to address complex patient needs. Local and regional manufacturers in Asia-Pacific and Europe are also strengthening competitiveness by offering cost-effective alternatives and developing advanced stent designs.

This blend of established dominance and emerging innovation ensures that patients worldwide have access to a diverse and evolving range of treatment options. The competitive environment is also accelerating innovation, as manufacturers push for simpler, safer, and more effective devices.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7693

Opportunities and Challenges Ahead

While the market outlook is positive, challenges remain. High device costs and limited awareness in low-income regions are barriers to adoption. Additionally, stringent regulatory frameworks, particularly in the United States and Europe, often slow down product launches and market entry for new players.

Nevertheless, opportunities outweigh these challenges. The rise of outpatient and day-surgery procedures, advancements in bioresorbable scaffolds, and growing integration of digital imaging with device navigation are setting the stage for the next wave of endovascular innovations. With cardiovascular disease still the leading cause of mortality worldwide, the demand for effective and minimally invasive treatments will only intensify.

Voices from the Industry

Industry experts emphasize that the coming decade will be defined by collaboration between global giants and emerging innovators. Larger manufacturers are expected to continue investing heavily in research and development, while smaller players will focus on niche advancements and patient-centric solutions. Together, they are shaping a market that prioritizes safety, efficiency, and accessibility.

Physicians, too, are welcoming the evolution of endovascular therapy. With advanced devices enabling shorter hospital stays and faster recovery, patient satisfaction rates are climbing, further cementing the role of these therapies in modern medicine.

Related Reports:

Pelvic Floor Stimulators Market: https://www.futuremarketinsights.com/reports/pelvic-floor-stimulator-market

Americas COVID-19 Testing Market: https://www.futuremarketinsights.com/reports/americas-covid-19-testing-market

Wet Wipes Market: https://www.futuremarketinsights.com/reports/wet-wipes-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:     

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com

Website: https://www.futuremarketinsights.com

LinkedIn| Twitter| Blogs | YouTube